Literature DB >> 22150162

Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan.

C-F Kuo1, S-F Luo, K-H Yu, I-J Chou, W-Y Tseng, H-C Chang, Y-F Fang, M-J Chiou, L-C See.   

Abstract

OBJECTIVES: Systemic sclerosis (SSc) has been associated with high cancer risk. We compared the cancer risk among SSc patients with that among the general Taiwanese population.
METHODS: The catastrophic illness registry of the Taiwan National Health Insurance Research Dataset (NHIRD) was used to identify patients diagnosed with SSc and cancer in Taiwan during 1996-2008. The standardized incidence ratio (SIR) for cancer was calculated, and mortality was ascertained using the data from the National Death Registry.
RESULTS: Data analysis revealed that 2053 (472 men, 1581 women) Taiwanese individuals were diagnosed with SSc during the study period and 83 (30 men, 53 women) had cancer. The incidence of cancer was 6.9/1000 person-years. The most common cancer sites in male SSc patients were the lung (n = 10), oral cavity and pharynx (n = 8), and gastrointestinal tract (n = 4), and those in female patients were the breast (n = 11), lungs (n = 11), and blood (n = 6). Compared to the Taiwanese population of 1996, the all-cancer SIR for SSc was 1.63 [95% confidence interval (CI) 1.31-2.01]. Cancer risk was elevated for cancers of the lung (SIR 4.20), oral cavity and pharynx (SIR 3.67), and blood (SIR 3.50). A cancer diagnosis in SSc patients was associated with a hazard ratio (HR) of 2.15 (95% CI 1.30-3.53). Among cancer patients, a diagnosis of SSc was not associated with increased mortality.
CONCLUSIONS: SSc patients are at high risk of developing cancer, especially of the lung, oral cavity and pharynx, and blood.

Entities:  

Mesh:

Year:  2011        PMID: 22150162     DOI: 10.3109/03009742.2011.618145

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  26 in total

Review 1.  Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening.

Authors:  Ami A Shah; Livia Casciola-Rosen
Journal:  Curr Opin Rheumatol       Date:  2015-11       Impact factor: 5.006

2.  Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival.

Authors:  Abdulla Watad; Dennis McGonagle; Nicola L Bragazzi; Shmuel Tiosano; Doron Comaneshter; Yehuda Shoenfeld; Arnon D Cohen; Howard Amital
Journal:  Oncoimmunology       Date:  2019-03-24       Impact factor: 8.110

Review 3.  Cancer and Scleroderma.

Authors:  Emma Weeding; Livia Casciola-Rosen; Ami A Shah
Journal:  Rheum Dis Clin North Am       Date:  2020-06-10       Impact factor: 2.670

Review 4.  Oral manifestations of systemic disease.

Authors:  S R Porter; V Mercadante; S Fedele
Journal:  Br Dent J       Date:  2017-11-10       Impact factor: 1.626

5.  Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer.

Authors:  Takeru Igusa; Laura K Hummers; Kala Visvanathan; Carrie Richardson; Fredrick M Wigley; Livia Casciola-Rosen; Antony Rosen; Ami A Shah
Journal:  Ann Rheum Dis       Date:  2018-04-20       Impact factor: 19.103

6.  Mechanistic and clinical insights at the scleroderma-cancer interface.

Authors:  Ami A Shah; Livia Casciola-Rosen
Journal:  J Scleroderma Relat Disord       Date:  2017-10-05

Review 7.  Orofacial consequences of systemic sclerosis: A systematic review.

Authors:  Rawen Smirani; Nicolas Poursac; Adrien Naveau; Thierry Schaeverbeke; Raphaël Devillard; Marie-Elise Truchetet
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

8.  Orofacial manifestations of systemic sclerosis.

Authors:  B J Veale; R Y Jablonski; T M Frech; J D Pauling
Journal:  Br Dent J       Date:  2016-09-23       Impact factor: 1.626

9.  Advances at the Interface of Cancer and Systemic Sclerosis.

Authors:  Christopher A Mecoli; Antony Rosen; Livia Casciola-Rosen; Ami A Shah
Journal:  J Scleroderma Relat Disord       Date:  2020-03-17

Review 10.  Prevalence of Oral and Maxillofacial Disorders in Patients with Systemic Scleroderma-A Systematic Review.

Authors:  Korbinian Benz; Christine Baulig; Stephanie Knippschild; Frank Peter Strietzel; Nicolas Hunzelmann; Jochen Jackowski
Journal:  Int J Environ Res Public Health       Date:  2021-05-14       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.